Publications

Articles scientifiques

Safety and tolerability of switching to bictegravir/emtricitabine/tenofovir alafenamide versus continuing dolutegravir/lamivudine in people living with HIV with neuropsychiatric comorbidities: Week 24 and 48 results from the Management of INSTI-associated Neuropsychiatric Disorders (MIND) clinical trial

Juillet 2026

Abstract To evaluate if switching from dolutegravir/lamivudine (DTG/3TC) to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) ...

Types

Sujets

Formations à venir

Webinaire – Évolution des drogues de rue : impacts sur les risques et les mesures de réduction des méfaits

Webinaire – Surveillance du VIH au Québec : portrait épidémiologique 2023-2024 et tendances récentes

Webinaire – VHB et VHD : il est temps de trouver et traiter davantage de patients

Actualités

Infolettres

Congrès externes à venir

Publications

À la une

Prep orale mensuelle (étude) – évaluation de la sécurité, tolérance et pharmacocinétique de l’alimatravir chez des adultes présentant une faible probabilité d’exposition au VIH

ASPC – Le VIH au Canada – Rapport de surveillance en date du 31 décembre 2024

Lignes directrices

Outils cliniques

À la une

La feuille de route du Québec en matière d’élimination de l’hépatite C

Substances psychoactives, tabac et jeux d’argent | INSPQ

Résultat(s)

Publications

Types

Sujets

Spécialités

Dernières publications

Efficacy and Safety of 12-Week Coblopasvir/Sofosbuvir Regimen for Hepatitis C in Northwest China: A Multi-Center Prospective Study

Risk factors of metabolic dysfunction-associated fatty liver disease in people with HIV receiving antiretroviral therapy

Incidence of HIV and HCV Among People Who Inject Drugs in Montreal, Canada: Data From the HEPCO Longitudinal Cohort Study, 2011–2025

Acute hepatitis C related to chemsex: insights from a Spanish cohort

Global mental health disparities among transgender women and transfeminine people living with HIV: a systematic review and meta-analysis of 63 studies

Short-cycle 4-days-per-week maintenance two-drug therapy in people living with HIV (ANRS-177 DUETTO): a randomised, open-label, multicentre, non-inferiority trial

Durability of doxycycline effectiveness against gonorrhoea after implementation of post-exposure prophylaxis in southern California, USA: a retrospective, test-negative, observational study

The risk of HIV and HCV transmission in Canadians living with coinfection before, during, and after the COVID pandemic: A prospective cohort study

Resolved HBV Infection Is Not Associated With Liver-Related Outcomes in Survival Analysis of Caucasians After HCV Cure

Policy changes in opioid agonist therapy and impacts on HIV and hepatitis C prevention in Canadian federal prisons

Chemsex and uptake of HIV pre-exposure prophylaxis among adult cisgender gay, bisexual and other men who have sex with men worldwide: a systematic review with meta-analysis

Neurocognitive and neuropsychiatric evaluation of individuals living with HIV compared to HIV uninfected individuals

Recurrent episodes of pneumonia are associated with worse lung function in people with HIV

Scaling up point-of-care hepatitis C testing in Canada: protocol for a multilevel implementation science study of clinical processes, barriers, facilitators and implementation strategies (SCALE-POCT study)

Beyond direct-acting antiviral therapy: Characterizing mental health conditions and depressive symptoms among patients recently treated for hepatitis C

Utilizing Telemedicine to Engage Rural Patients With Substance Use Disorders in Low Barrier Hepatitis C Treatment

Reach and effectiveness outcomes of the “I’m Ready” HIV self-testing program in Black communities in Canada

Beyond protection: navigating biomedical HIV prevention and risk compensation in MSM, 2018–2024

Chemsex and uptake of HIV pre-exposure prophylaxis among adult cisgender gay, bisexual and other men who have sex with men worldwide: a systematic review with meta-analysis

Prevalence and Factors Associated With Hepatitis C in Danish Prisons, 2022–2024: A Multicentre Cross-Sectional Study

Setting the Record Straight: Utility and Outcomes in Patients With HCV Related HCC

Prevalence of Active HCV Infection in Spain in 2022 Using Multiparameter Evidence Synthesis

Hypertriglyceridaemia and gender differences in the risk of major adverse cardiovascular events in people with HIV: A single-centre retrospective longitudinal study

Pre-exposure prophylaxis (PrEP) uptake and retention in care in a group of transgender women at high risk of HIV: a French cohort of follow-up

Intersecting Vulnerabilities: The Role of Housing Instability and Methamphetamine Use on HIV Acquisition

Tenofovir Alafenamide Fumarate Reduces Virological Replication in HBeAg-Negative Patients With Normal Alanine Aminotransferase: A 48-Week Randomised Controlled Trial

Mobile Telemedicine for Treating Chronic Hepatitis C Among Rural People Who Inject Drugs – A Randomized Clinical Trial

Risk of Hepatocellular Carcinoma After Direct-Acting Antiviral Treatment for Hepatitis C Virus Infection in People With Human Immunodeficiency Virus

Estimated major adverse cardiovascular events averted among persons with HIV if treated with a moderate-intensity statin